Loading...
By Kristin J. Kelley
Edited by André Sofair, MD, MPH
The FDA has announced a voluntary recall of several valsartan-containing heart drugs because they've been contaminated with N-nitrosodimethylamine (NDMA), a probable human carcinogen. Valsartan products have been recalled in 22 other countries, CNN reports.
The recall affects drugs made by specific manufacturers, the FDA notes, and not all drugs containing valsartan are involved. See the linked news release for a list of affected products. The agency is investigating what can be done to eliminate NDMA from future batches.
Patients are advised to continue taking their valsartan-containing medications, which treat heart failure and high blood pressure, until they find an alternative treatment.
Comment
LINK(S):
FDA news release (Free)
CNN story (Free)
Background: Physician's First Watch coverage of heart failure treatment guidelines that include valsartan (Free)